rs115577037
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000751.3(CHRND):c.1372-50T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,606,916 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0067 ( 11 hom., cov: 33)
Exomes 𝑓: 0.00064 ( 9 hom. )
Consequence
CHRND
NM_000751.3 intron
NM_000751.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.53
Publications
1 publications found
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
- congenital myasthenic syndrome 3AInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital myasthenic syndrome 3BInheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- congenital myasthenic syndrome 3CInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-232535080-T-G is Benign according to our data. Variant chr2-232535080-T-G is described in ClinVar as Likely_benign. ClinVar VariationId is 256779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00669 (1019/152308) while in subpopulation AFR AF = 0.023 (958/41570). AF 95% confidence interval is 0.0218. There are 11 homozygotes in GnomAd4. There are 462 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRND | NM_000751.3 | c.1372-50T>G | intron_variant | Intron 11 of 11 | ENST00000258385.8 | NP_000742.1 | ||
| CHRND | NM_001256657.2 | c.1327-50T>G | intron_variant | Intron 10 of 10 | NP_001243586.1 | |||
| CHRND | NM_001311196.2 | c.1069-50T>G | intron_variant | Intron 11 of 11 | NP_001298125.1 | |||
| CHRND | NM_001311195.2 | c.790-50T>G | intron_variant | Intron 9 of 9 | NP_001298124.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRND | ENST00000258385.8 | c.1372-50T>G | intron_variant | Intron 11 of 11 | 1 | NM_000751.3 | ENSP00000258385.3 | |||
| CHRND | ENST00000543200.5 | c.1327-50T>G | intron_variant | Intron 10 of 10 | 2 | ENSP00000438380.1 | ||||
| CHRND | ENST00000441621.6 | n.*554-50T>G | intron_variant | Intron 10 of 10 | 5 | ENSP00000408819.2 | ||||
| CHRND | ENST00000446616.1 | n.*1013-50T>G | intron_variant | Intron 11 of 11 | 3 | ENSP00000410801.1 |
Frequencies
GnomAD3 genomes AF: 0.00672 AC: 1022AN: 152190Hom.: 11 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1022
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00177 AC: 437AN: 247144 AF XY: 0.00120 show subpopulations
GnomAD2 exomes
AF:
AC:
437
AN:
247144
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000637 AC: 926AN: 1454608Hom.: 9 Cov.: 31 AF XY: 0.000507 AC XY: 367AN XY: 723882 show subpopulations
GnomAD4 exome
AF:
AC:
926
AN:
1454608
Hom.:
Cov.:
31
AF XY:
AC XY:
367
AN XY:
723882
show subpopulations
African (AFR)
AF:
AC:
781
AN:
33348
American (AMR)
AF:
AC:
52
AN:
44624
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26042
East Asian (EAS)
AF:
AC:
0
AN:
39676
South Asian (SAS)
AF:
AC:
0
AN:
86000
European-Finnish (FIN)
AF:
AC:
0
AN:
51868
Middle Eastern (MID)
AF:
AC:
0
AN:
4632
European-Non Finnish (NFE)
AF:
AC:
11
AN:
1108316
Other (OTH)
AF:
AC:
82
AN:
60102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
57
114
171
228
285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00669 AC: 1019AN: 152308Hom.: 11 Cov.: 33 AF XY: 0.00620 AC XY: 462AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
1019
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
462
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
958
AN:
41570
American (AMR)
AF:
AC:
42
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68012
Other (OTH)
AF:
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
53
106
158
211
264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Oct 06, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.